Tempest Therapeutics
IPO
- Headquarters
- Brisbane, California
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B
- Website
- tempesttx.com
- Total Funding
- $85.0M
- Last Round
- $15.0M Private EquityApr 2022
About
A clinical-stage oncology company advancing small molecules that combine both targeted and immune-mediated mechanisms with the potential to treat a wide range of tumors.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account